Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | RAC2 | P15153 | 1/20 | 0.31 |
| ▸ | RAC3 | P60763 | 1/20 | 0.31 |
| ▸ | CDC42 | P60953 | 1/20 | 0.31 |
| ▸ | RAC1 | P63000 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16357514 | 0.96 | KDM4E (0.41) | KDM4EATML3MBTL1TSHRHSD17B10 | |
| SCHEMBL15802028 | 0.92 | KDM4E (0.39) | KDM4EATML3MBTL1TSHRHSD17B10 | |
| SCHEMBL15802139 | 0.92 | KDM4E (0.39) | KDM4EATML3MBTL1TSHRHSD17B10 | |
| SCHEMBL20426273 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1TSHRHSD17B10 | |
| SCHEMBL15802364 | 0.89 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL15857519 | 0.88 | KDM4E (0.38) | KDM4EATML3MBTL1TSHRHSD17B10 | |
| SCHEMBL15857192 | 0.88 | KDM4E (0.38) | KDM4EATML3MBTL1TSHRHSD17B10 | |
| SCHEMBL15857195 | 0.88 | KDM4E (0.38) | KDM4EATML3MBTL1TSHRHSD17B10 | |
| SCHEMBL20427218 | 0.88 | MAPT (0.39) | KDM4EATML3MBTL1TSHRHSD17B10 | |
| SCHEMBL20427126 | 0.87 | CYP19A1 (0.42) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | IDO1, IDO2, KYNU | KDM4E 1494/4885ATM 4017/4885L3MBTL1 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.